Search Within

Shanu Modi

  1. "2016"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (5)
Groups
  1. Breast Medicine Service (12)
  2. Department of Medicine (12)
  3. Solid Tumor Oncology Division (12)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  5. Epidemiology and Biostatistics (6)
  6. Survivorship Research (6)

More Groups

People
  1. Clifford Hudis (6)
  2. Sujata Patil (5)
  3. Jose Baselga (4)
  4. Larry Norton (4)
  5. Neil Iyengar (4)
  6. Chau Dang (3)

More People

Years
  1. 2016 (12)
Publications
  1. Cancer Research (5)
  2. Annals of Oncology (2)
  3. Clinical Breast Cancer (2)
  4. Breast Cancer Research (1)
  5. Discovery Medicine (1)
  6. Nature (1)
Publishers
  1. American Association for Cancer Research (5)
  2. Elsevier Inc. (2)
  3. Oxford University Press (2)
  4. Biomed Central Ltd (1)
  5. Nature Publishing Group (1)
  6. Solariz, Inc. (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (pts) with solid tumors
    Meeting Abstract

    Modi, S.; Eder, J. P.; Lorusso, P.; Weekes, C.; Chandarlapaty, S.; Tolaney, S. M.; McLaughlin, J.; Camidge, D. R.; Chang, C. W.; Nazzal, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Iyengar, N.; Morris, P. G.; Corben, A. D.; Patil, S.; Akram, M.; Towers, R.; Sakr, R. A.; King, T. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Neratinib for ERBB2 mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial
    Meeting Abstract

    Hyman, D. M.; Piha-Paul, S. A.; RodoĢn, J.; Saura, C.; Puzanov, I.; Shapiro, G. I.; Loi, S.; Joensuu, H.; Hanrahan, A. J.; Modi, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Triplet therapy with ribociclib, everolimus, and exemestane in women with HR+/HER2- advanced breast cancer
    Meeting Abstract

    Bardia, A.; Modi, S.; Oliveira, M.; Campone, M.; Ma, B.; Dirix, L.; Weise, A.; Nardi, L.; Zhang, V.; Bhansali, S. G.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with metastatic breast cancer
    Meeting Abstract

    Forero, A.; Burris, H. 3rd; Mita, M.; Specht, J.; Weise, A.; Liu, M. C.; Modi, S.; Pusztai, L.; Kostic, A.; Yang, J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • A phase I trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; Haque, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer
    Journal Article

    Krop, I. E.; Modi, S.; LoRusso, P. M.; Pegram, M.; Guardino, E.; Althaus, B.; Lu, D.; Strasak, A.; Elias, A.
    Breast Cancer Research (2016)

    Fulltext@MSK | Save